Abaloparatide for osteoporosis, cost-effectiveness of PCSK9 inhibitors, review of aortic dissection, and more

JAMA Editor’s Summary

Abaloparatide for osteoporosis, cost-effectiveness of PCSK9 inhibitors, review of aortic dissection, and more

Editor's Audio Summary by Edward Livingston, MD, Deputy Editor, JAMA, the Journal of the American Medical Association, for the

August 16, 2016

Listen on your favorite player Take me to this show’s page

Newer →

Distinguishing bacterial from viral infection in young children, team-based care and health care quality, managing prescription drug costs, and more

← Older

Stroke prevention during TAVR, lipid screening in children and adolescents, clinical manifestations of CKD in diabetes, and more

Facebook Twitter Buffer LinkedIn WhatsApp

Abaloparatide for osteoporosis, cost-effectiveness of PCSK9 inhibitors, review of aortic dissection, and more

Editor’s Audio Summary by Edward Livingston, MD, Deputy Editor, JAMA, the Journal of the American Medical Association, for the August 16, 2016 issue

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

00:00

00:00